首页> 美国卫生研究院文献>Cardiovascular Diabetology >The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

【2h】

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

机译：胰高血糖素样肽-1受体激动剂艾塞那肽或胰岛素治疗与2型糖尿病患者心血管结局的关系：一项回顾性观察研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundTo evaluate the association of treatment with glucagon-like peptide-1 (GLP-1) receptor agonist exenatide and/or insulin on macrovascular outcomes in patients with type 2 diabetes (T2DM).

机译：背景为了评估胰高血糖素样肽-1（GLP-1）受体激动剂艾塞那肽和/或胰岛素与2型糖尿病（T2DM）患者大血管结局的治疗联系。

著录项

期刊名称 Cardiovascular Diabetology
作者
Sanjoy K Paul; Kerenaftali Klein; David Maggs; Jennie H Best;
展开▼
作者单位

展开▼
年(卷),期 2015(14),-1
年度 2015
页码 10
总页数 9
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
Exenatide Insulin Macrovascular outcomes Type 2 diabetes Pharmaco-epidemiology;

机译：艾塞那肽;胰岛素;大血管结局;2型糖尿病;药物流行病学;

相似文献

外文文献
中文文献
专利

1. The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study [J] . Sanjoy K Paul, Kerenaftali Klein, David Maggs, Cardiovascular Diabetology . 2015,第1期

机译：胰高血糖素样肽-1受体激动剂艾塞那肽或胰岛素治疗与2型糖尿病患者心血管结局的关系：一项回顾性观察研究
2. Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study [J] . Xuejun Victor Peng, Rajeev Ayyagari, Robert Lubwama, Diabetes therapy . 2020,第4期

机译：基部胰岛素和胰高血糖素样肽-1受体激动剂对2型糖尿病患者的影响：回顾性观察研究
3. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes [J] . Mike Baxter, Yukiko Morimoto, Masami Tamiwa, Diabetes therapy . 2020,第7期

机译：一种真实的观察性研究，评估血糖控制与基础胰岛素或胰高血糖素样肽-1受体激动剂在2型糖尿病患者中的胰腺癌概率
4. Treatment of Diabetes and Obesity by Rationally Designed Peptide Agonists Functioning at Multiple Metabolic Receptors [C] . Noushafarin Khajavi, Heike Biebermann, Matthias Tschop, ESPE Advanced Seminar in Developmental Endocrinology . 2017

机译：通过在多种代谢受体中起作用的合理设计肽激动剂治疗糖尿病和肥胖症
5. Combinatorial targeting of the glucagon-like peptide-1 and sulfonylurea-1 receptors using a complimentary mulitvalent glucagon-like peptide-1/glibenclamide ligand for the improvement of beta-cell targeting agents and diabetic treatment. [D] . Hart, Nathaniel. 2013

机译：使用互补的多价胰高血糖素样肽-1 /格列苯脲酰胺配体对胰高血糖素样肽-1和磺酰脲-1受体进行联合靶向，以改善β细胞靶向剂和糖尿病治疗。
6. Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study [O] . Xuejun Victor Peng, Rajeev Ayyagari, Robert Lubwama, 2020

机译：基线胰岛素和胰高血糖素样肽-1受体激动剂同时同时序贯启动对2型糖尿病HbA1c的影响：一项回顾性观察研究。
7. The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study [O] . Sanjoy K Paul, Kerenaftali Klein, David Maggs, 2015

机译：胰高血糖素样肽-1受体激动剂艾塞那肽或胰岛素治疗与2型糖尿病患者心血管结局的关系：一项回顾性观察研究

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study

摘要

著录项

相似文献

相关主题

期刊订阅